Trials / Unknown
UnknownNCT02168764
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Autonomic Technologies, Inc. · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to demonstrate the safety and efficacy of SPG stimulation with the ATI Neurostimulation System when used to treat acute cluster attacks in chronic cluster headache patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ATI Neurostimulation System | All subjects will be implanted with the ATI Neurostimulator which, along with the ATI Remote Controller, provides electrical stimulation. |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2019-03-01
- Completion
- 2020-03-01
- First posted
- 2014-06-20
- Last updated
- 2018-06-26
Locations
24 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02168764. Inclusion in this directory is not an endorsement.